Lymphocyte-to-monocyte ratio is a predictor of clinically significant prostate cancer at prostate biopsy,The Prostate

当前位置： X-MOL 学术 › Prostate › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Lymphocyte-to-monocyte ratio is a predictor of clinically significant prostate cancer at prostate biopsy
The Prostate ( IF 2.8 ) Pub Date : 2021-09-13 , DOI: 10.1002/pros.24222
Min Chul Cho _{1,

2} , Sangjun Yoo _{1,

2} , Min Soo Choo _{1,

2} , Hwancheol Son _{1,

2} , Hyeon Jeong _{1,

2}

Affiliation

Inflammation plays critical roles at different stages of carcinogenesis and cancer progression. Several previous studies showed conflicting results for the predictive role of systemic inflammation markers in the detection of clinically significant prostate cancers (CSPCs). We aimed to determine the predictive roles of lymphocyte-to-monocyte (LMR) and eosinophil-to-lymphocyte ratios (ELR) in the detection of CSPC at standard 12-core transrectal ultrasound-guided prostate biopsy (12-core-TRUS-Bx) using our large-cohort database.

中文翻译：

淋巴细胞与单核细胞的比率是前列腺活检中具有临床意义的前列腺癌的预测指标

炎症在癌变和癌症进展的不同阶段起着关键作用。先前的几项研究显示，全身炎症标志物在检测临床显着前列腺癌 (CSPC) 中的预测作用存在相互矛盾的结果。我们旨在确定淋巴细胞与单核细胞 (LMR) 和嗜酸性粒细胞与淋巴细胞比率 (ELR) 在标准 12 芯经直肠超声引导前列腺活检 (12 芯-TRUS-Bx) 中检测 CSPC 的预测作用) 使用我们的大型群组数据库。

更新日期：2021-11-03

点击分享查看原文

点击收藏

阅读更多本刊最新论文

全部期刊列表>>